The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin
Open accessAbstract
The modulating effects of dietary feeding of two flavonoids, diosmin and hesperidin, both alone and in combination, during the initiation and post-initiation phases on colon carcinogenesis initiated with azoxymethane (AOM), were investigated in male F344 rats. Animals were initiated with AOM by weekly s.c. injections of 15 mg/kg body wt for 3 weeks to induced colon neoplasms. Rats were fed the diets containing diosmin (1000 ppm), hesperidin (1000 ppm) or diosmin (900 ppm) + hesperidin (100 ppm) for 5 weeks (initiation treatment) or 28 weeks (post-initiation treatment). The others contained the groups of rats treated with diosmin, hesperidin alone or in combination, and untreated. At the end of the study (32 weeks), the incidence and multiplicity of neoplasms (adenoma and adenocarcinoma) in the large intestine of rats initiated with AOM together with, or followed by, a diet containing diosmin or hesperidin were significantly smaller than those of rats given AOM alone (P <0.001). The combination regimen during the initiation and post-initiation stages also inhibited the development of colonic neoplasms, but the tumor data did not indicate any beneficial effect of diosmin and hesperidin administered together as compared with when these agents were given individually. In addition, feeding of diosmin and hesperidin, both alone and in combination, significantly inhibited the development of aberrant crypt foci. As for cell proliferation biomarkers, dietary exposure of diosmin and hesperidin significantly decreased the 5'-bromodeoxyuridine-labeling index and argyrophilic nuclear organizer region's number in crypt cells, colonic mucosal ornithine decarboxylase activity, and polyamine levels in the blood. These results indicate that diosmin and hesperidin, both alone and in combination, act as a chemopreventive agent against colon carcinogenesis, and such effects may be partly due to suppression of cell proliferation in the colonic crypts, although precise mechanisms should be clarified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.
Pegg, A. E. (1988) · PubMed · Cited by 1,528
(2008) · Encyclopedia of Genetics, Genomics, Proteomics and Informatics · doi:10.1007/978-1-4020-6754-9_2795 · Cited by 1,243
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., & Hla, T. (1995) · PubMed · Cited by 1,126
Cell Proliferation in Carcinogenesis
Cohen, S. M., & Ellwein, L. B. (1990) · Science · doi:10.1126/science.2204108 · Cited by 1,050
Role of Polyamines in the Control of Cell Proliferation and Differentiation
HEBY, O. (1981) · Differentiation · doi:10.1111/j.1432-0436.1981.tb01123.x · Cited by 936
Role of aberrant crypt foci in understanding the pathogenesis of colon cancer
Bird, R. P. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03788-x · Cited by 570
Waterman, P. G. (1986) · Phytochemistry · doi:10.1016/s0031-9422(00)84553-7 · Cited by 554
Hirayama, T. (1979) · Nutrition and Cancer · doi:10.1080/01635587909513632 · Cited by 543
Aberrant crypts: putative preneoplastic foci in human colonic mucosa.
Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Jurcisek, J. A., & Stellato, T. A. (1991) · PubMed · Cited by 445
Effects of flavonoids on nonenzymatic lipid peroxidation: Structure-activity relationship
Ratty, A. K., & Das, N. P. (1988) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(88)90060-6 · Cited by 414
Lipkin, M. (1988) · PubMed · Cited by 381
Antimutagenesis and Anticarcinogenesis Mechanisms
(1986) · Springer eBooks · doi:10.1007/978-1-4684-5182-5 · Cited by 374
Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids
Weisburger, J. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.1.226s · Cited by 212
Micronutrients and cancer risk
Willett, W. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.5.1162s · Cited by 143
Tanaka, T., Makita, H., Ohnishi, M., Mori, H., Satoh, K., Hara, A., Sumida, T., Fukutani, K., Tanaka, T., & Ogawa, H. (1997) · PubMed · Cited by 110
Self-citationSafety and Security of Daflon 500 mg in Venous Insufficiency and in Hemorrhoidal Disease
Meyer, O. (1994) · Angiology · doi:10.1177/000331979404500614 · Cited by 104
Inhibition of tumor promotion by flavonoids.
Fujiki, H., Horiuchi, T., Yamashita, K., Hakii, H., Suganuma, M., Nishino, H., Iwashima, A., Hirata, Y., & Sugimura, T. (1986) · PubMed · Cited by 43
Cited by
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
By-products of plant food processing as a source of functional compounds—Recent developments
Schieber, A., Stintzing, F. C., & Carle, R. (2001) · Trends in Food Science & Technology · doi:10.1016/s0924-2244(02)00012-2 · Cited by 1,334
Dietary agents in cancer prevention: flavonoids and isoflavonoids
Birt, D. F., Hendrich, S., & Wang, W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00137-1 · Cited by 1,171
Benavente-García, O., & Castillo, J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8006568 · Cited by 1,158
Flavonoids: Promising anticancer agents
Ren, W., Qiao, Z., Wang, H., Zhu, L., & Zhang, L. (2003) · Medicinal Research Reviews · doi:10.1002/med.10033 · Cited by 1,150
Metadata
- Authors
- Tanaka, T.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-05-01
- Volume
- 18
- Issue
- 5
- Pages
- 957-965
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W1983107157
- Cited by
- 297
- References
- 17
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.